ALICR Stock Overview
I.CERAM SA designs, manufactures, and markets alumina-based ceramic implants in France and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
I.CERAM SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.30 |
52 Week High | €9.70 |
52 Week Low | €1.30 |
Beta | 1.22 |
1 Month Change | -59.38% |
3 Month Change | -52.21% |
1 Year Change | -85.84% |
3 Year Change | -96.46% |
5 Year Change | -98.46% |
Change since IPO | -99.00% |
Recent News & Updates
Shareholder Returns
ALICR | FR Medical Equipment | FR Market | |
---|---|---|---|
7D | -15.6% | 0.6% | 0.4% |
1Y | -85.8% | 27.4% | 9.6% |
Return vs Industry: ALICR underperformed the French Medical Equipment industry which returned 27.7% over the past year.
Return vs Market: ALICR underperformed the French Market which returned 10.6% over the past year.
Price Volatility
ALICR volatility | |
---|---|
ALICR Average Weekly Movement | 28.9% |
Medical Equipment Industry Average Movement | 5.3% |
Market Average Movement | 4.2% |
10% most volatile stocks in FR Market | 9.8% |
10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: ALICR's share price has been volatile over the past 3 months.
Volatility Over Time: ALICR's weekly volatility has increased from 20% to 29% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 25 | André Kérisit | https://www.iceram.fr |
I.CERAM SA designs, manufactures, and markets alumina-based ceramic implants in France and internationally. It offers implants for various joints of the human body, including skull, spine, hip, tibia, ankle, foot, and thorax, as well as osteosynthesis products. The company was incorporated in 2005 and is headquartered in Limoges, France.
I.CERAM SA Fundamentals Summary
ALICR fundamental statistics | |
---|---|
Market cap | €379.01k |
Earnings (TTM) | -€903.07k |
Revenue (TTM) | €1.04m |
0.4x
P/S Ratio-0.4x
P/E RatioIs ALICR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALICR income statement (TTM) | |
---|---|
Revenue | €1.04m |
Cost of Revenue | €759.57k |
Gross Profit | €280.54k |
Other Expenses | €1.18m |
Earnings | -€903.07k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -3.10 |
Gross Margin | 26.97% |
Net Profit Margin | -86.82% |
Debt/Equity Ratio | 103.5% |
How did ALICR perform over the long term?
See historical performance and comparison